Freeline Therapeutics (FRLN)
NASDAQ: FRLN
· Real-Time Price · USD
6.49
0.01 (0.15%)
At close: Feb 16, 2024, 9:37 PM
Freeline Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.39 | -0.17 | 6.36 | -0.34 | -0.76 | -0.58 | -0.45 | -0.51 | -0.99 | -1.82 | -3.14 |
PEG Ratio | 0.02 | 0.00 | -0.06 | -0.01 | 0.02 | 0.01 | 0.01 | -0.04 | 0.04 | -0.13 | 0.41 |
PS Ratio | 3.75K | 18.16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.62 | 0.27 | 0.53 | 0.59 | 0.66 | 0.63 | 0.40 | 0.59 | 0.80 | 1.57 | 2.00 |
P/FCF Ratio | -2.16 | -0.64 | -1.57 | -1.3 | -2.62 | -3.3 | -1.76 | -3.95 | -5.15 | -8.62 | -12.01 |
P/OCF Ratio | -2.16 | -0.65 | -1.61 | -1.55 | -3 | -3.38 | -1.8 | -4.09 | -5.37 | -8.72 | -12.81 |
OCF/S Ratio | -1.73K | -28 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.13 | 0.11 | 0.10 | 0.11 | 0.17 | 0.64 | 0.50 | n/a | n/a | n/a | n/a |
Quick Ratio | 1.90 | 2.40 | 2.64 | 1.61 | 3.13 | 3.60 | 4.66 | 5.89 | 8.72 | 12.11 | 14.03 |
Current Ratio | 1.95 | 2.45 | 2.81 | 2.18 | 3.31 | 3.68 | 4.82 | 6.20 | 8.82 | 12.21 | 14.13 |
Asset Turnover | 0.00 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -3.11 | -79.42 | -107.14 | n/a | n/a | -415.28 | n/a | n/a |
Return on Equity | -0.4 | -0.38 | 0.02 | -0.44 | -0.22 | -0.27 | -0.23 | -0.29 | -0.2 | -0.21 | -0.16 |
Return on Assets | -0.25 | -0.26 | 0.01 | -0.27 | -0.15 | -0.15 | -0.14 | -0.25 | -0.18 | -0.2 | -0.15 |
Return on Invested Capital | -0.36 | -0.33 | -0.29 | -0.34 | -0.29 | -0.18 | -0.16 | -0.29 | -0.23 | -0.21 | -0.15 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -75.75 | 0.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -2.42K | -25.95 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -2.41K | -25.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -2.45K | -25.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -2.31K | -31 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |